JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.
Expert Ratings for Allegion
Analysts have provided the following ratings for Allegion (NYSE:ALLE) within the last quarter:
JonesTrading Downgrades Concert Pharma to Hold
JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.
Related Posts
‘Google approves Truth Social for Play Store’ -Axios
https://www.axios.com/2022/10/12/google-approves-truth-social-app-play-store?utm_source=twitter&utm_medium=social&utm_campaign=editorial
HP At Forefront Of Upcoming AI Revolution In PC Industry, CEO Says
HP Inc. (NYSE:HPQ) CEO Enrique Lores believes that artificial intelligence, or AI, will revolutionize the personal computer industry,…
Inuvo AI Enhances Its Audience Descriptions By Utilizing OpenAI
Inuvo, Inc. (NYSE:INUV), provider of the first generative artificial intelligence (AI) advertising solution made specifically for brands and agencies, today announced that its generative AI technology,